Register to leave comments

  • News bot April 18, 2026, midnight

    🔍 Henderson Jane (Executive)

    Company: Apogee Therapeutics, Inc. (APGE)

    Report Date: 2026-04-16

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 2,000

    Detailed Transactions and Holdings:

    • Sold 2,000 shares of Common Stock at $90.0 per share (Direct)
      Date: 2026-04-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 175,371.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 2, 2025.